MARKET

SCNI

SCNI

Scinai Immunotherapeutics Ltd.
NASDAQ
1.200
+0.130
+12.15%
After Hours: 1.150 -0.05 -4.16% 19:16 12/05 EST
OPEN
1.130
PREV CLOSE
1.070
HIGH
1.200
LOW
1.070
VOLUME
150.57K
TURNOVER
--
52 WEEK HIGH
6.18
52 WEEK LOW
0.8600
MARKET CAP
4.16M
P/E (TTM)
0.1502
1D
5D
1M
3M
1Y
5Y
1D
Scinai Immunotherapeutics Reports Growth and Pipeline Progress
TipRanks · 3d ago
Scinai Immunotherapeutics Reports Nine-Month 2025 Results and Strategic Developments
TipRanks · 3d ago
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances
PR Newswire · 3d ago
Weekly Report: what happened at SCNI last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at SCNI last week (1117-1121)?
Weekly Report · 11/24 09:07
Weekly Report: what happened at SCNI last week (1110-1114)?
Weekly Report · 11/17 09:07
Scinai Immunotherapeutics Announces December 2025 Shareholder Meeting
TipRanks · 11/13 22:41
Scinai Immunotherapeutics Announces Board Changes and New Accounting Firm Amid Cost-Cutting Efforts
TipRanks · 11/13 22:26
More
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.

Webull offers Scinai Immunotherapeutics Ltd - ADR stock information, including NASDAQ: SCNI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNI stock methods without spending real money on the virtual paper trading platform.